Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study

Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study

Background: Group B streptococcus is the leading cause of infection in infants. Currently, intrapartum antibiotic prophylaxis is the major strategy to prevent invasive group B streptococcus disease. However, intrapartum antibiotic prophylaxis does not prevent maternal sepsis, premature births, still...

Full description

Bibliographic Details
Main Authors: Clara Carreras-Abad, Madeleine Cochet, Tom Hall, Laxmee Ramkhelawon, Asma Khalil, Elisabeth Peregrine, Latha Vinayakarao, Sharmila Sivarajan, Rosol Hamid, Tim Planche, Elizabeth Sheridan, Stephen Winchester, Jane Plumb, Abdelmajid Djennad, Nick Andrews, Kirsty Le Doare, Paul Heath
Format: Article
Language:English
Published: NIHR Journals Library 2019-12-01
Series:Health Technology Assessment
Subjects:
streptococcus agalactiae
group b streptococcus
immunisation
sepsis
meningitis
newborn
infant
Online Access:https://doi.org/10.3310/hta23670

Similar Items

Similar Items